**Core Concept**
Calcium channel blockers (CCBs) are a class of medications that inhibit the influx of calcium ions into cardiac and smooth muscle cells, leading to vasodilation and decreased cardiac contractility. This pharmacological effect is primarily mediated through the blockade of L-type calcium channels.

**Why the Correct Answer is Right**
Calcium channel blockers are useful in various clinical conditions, including hypertension, angina pectoris, and certain types of arrhythmias. They are also used in the management of heart failure and as a prophylactic measure for migraine headaches. The mechanism of action involves the inhibition of the L-type calcium channels, which reduces the intracellular calcium concentration and leads to relaxation of smooth muscle and decreased cardiac contractility.

**Why Each Wrong Option is Incorrect**
**Option A:** CCBs are not typically used in the treatment of acute myocardial infarction (MI). While they may be beneficial in certain cases of MI, their primary use is not in the acute management of MI.
**Option B:** CCBs are not typically used in the treatment of asthma. In fact, CCBs can cause bronchoconstriction in patients with asthma, making them a contraindication in this population.
**Option C:** CCBs are not typically used in the treatment of Parkinson's disease. While dopamine and calcium channels interact in the brain, CCBs do not have a direct role in the management of Parkinson's disease.

**Clinical Pearl / High-Yield Fact**
A key consideration when using CCBs is their potential to cause reflex tachycardia, particularly in patients with atrial fibrillation or flutter. This can lead to an increase in cardiac output, which may exacerbate symptoms of heart failure.

**Correct Answer: B. CCBs are not typically used in the treatment of asthma.